Alpha Cognition (ACOGF) News Today Add Compare Share Share Headlines Stock AnalysisHeadlinesBuy This Stock ACOGF Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Insiders Rewarded With US$150k Addition To Investment As Alpha Cognition Stock Hits US$144mSeptember 9, 2025 | uk.finance.yahoo.comAlpha Cognition files $250M mixed securities shelfAugust 22, 2025 | msn.comAlpha Cognition Inc. Common Stock (ACOG)June 24, 2025 | finance.yahoo.comAlpha Cognition Inc. Common Stock (ACOG): A Bull Case TheoryJune 6, 2025 | insidermonkey.comWe Think Alpha Cognition (NASDAQ:ACOG) Can Easily Afford To Drive Business GrowthMay 17, 2025 | finance.yahoo.comAlpha Cognition Inc. (ACOG) Q1 2025 Earnings Call TranscriptMay 15, 2025 | seekingalpha.comAlpha Cognition Inc. Reports First Quarter 2025 Financial Results and Operating OverviewMay 15, 2025 | finance.yahoo.comAlpha Cognition to Report First Quarter 2025 Financial Results and Operating OverviewMay 1, 2025 | financialpost.comFAlpha Cognition Earnings Call: Positive Outlook Amid GrowthApril 9, 2025 | tipranks.comAlpha Cognition Inc. Common Stock (NASDAQ:ACOG) Q4 2024 Earnings Call TranscriptApril 1, 2025 | msn.com Alpha Cognition Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Operating OverviewMarch 31, 2025 | financialpost.comFAlpha Cognition to Report Fourth Quarter and Full Year 2024 Financial Results and Operating OverviewMarch 19, 2025 | financialpost.comFAlpha Cognition commercially launches ZUNVEYL to treat mild to moderate ADMarch 18, 2025 | markets.businessinsider.comAlpha Cognition Announces the Commercial Launch of ZUNVEYL (Benzgalantamine) for the Treatment of Mild to Moderate Alzheimer’s DiseaseMarch 18, 2025 | theglobeandmail.comAlpha Cognition initiated with a Buy at H.C. WainwrightMarch 18, 2025 | markets.businessinsider.comAlpha Cognition Inc. Common Stock (ACOG): A Bull Case TheoryMarch 5, 2025 | insidermonkey.comAlpha Cognition sets new executive and director compensationMarch 1, 2025 | investing.comAlpha Cognition Inc. (NASDAQ:ACOG) surges 13%; retail investors who own 46% shares profited along with institutionsFebruary 20, 2025 | finance.yahoo.comAlpha Cognition secures additional patent for Zunveyl from USPTOFebruary 12, 2025 | markets.businessinsider.comAlpha Cognition Secures Additional U.S. Patent for ZUNVEYL (benzgalantamine) in the Treatment of Mild to Moderate Alzheimer's diseaseFebruary 12, 2025 | businesswire.comAlpha Cognition Inc. (ACOG)January 30, 2025 | ca.finance.yahoo.comAlpha Cognition Expands Commercial and Medical Teams with Key Leadership Hires to Support the Launch of ZUNVEYLJanuary 14, 2025 | finance.yahoo.comAlpha Cognition makes strategic personnel appointments to support ZUNVEYL launchJanuary 14, 2025 | markets.businessinsider.comAlpha Cognition, China Medical System enter exclusive Zunveyl licensing pactJanuary 9, 2025 | markets.businessinsider.comAlpha Cognition Raises $52.8 Million in Stock OfferingDecember 16, 2024 | tipranks.comAlpha Cognition Reports Promising Data for Brain Injury DrugDecember 16, 2024 | tipranks.comAlpha Cognition to delist from Canadian Securities ExchangeDecember 13, 2024 | msn.comAlpha Cognition: Data support ALPHA-1062 develpment for militaryTBI treatmentDecember 12, 2024 | markets.businessinsider.comAlpha Cognition sees promising data for military-related trauma treatmentDecember 11, 2024 | msn.comAlpha Cognition Inc Ordinary SharesNovember 20, 2024 | morningstar.comMAlpha Cognition IncNovember 14, 2024 | cnn.comAlpha Cognition Announces Pricing of $50 Million Upsized Public Offering and Nasdaq ListingNovember 12, 2024 | finance.yahoo.comThe Alpha Bridge Technique Can Help You Fall Asleep Faster—Here's How to Use the Viral TikTok MethodNovember 5, 2024 | msn.comAlpha Cognition Announces Proposed Financing and Share Consolidation in connection with Nasdaq UplistingOctober 31, 2024 | finance.yahoo.comAlpha Cognition Announces Appointment of VP Finance and AccountingOctober 21, 2024 | finance.yahoo.comAlpha Cognition Inc. (ACOGF)October 1, 2024 | finance.yahoo.comSpartan Capital Securities Serves as Selling Group Member in Alpha Cognition Inc.'s $4.454 Million Convertible Note and Warrants Bridge FinancingOctober 1, 2024 | globenewswire.comAlpha Cognition Announces Completion of $4.545 Million (USD) Convertible Note and Warrants Bridge FinancingSeptember 24, 2024 | businesswire.comTop TSX Growth Companies With High Insider Ownership September 2024September 24, 2024 | finance.yahoo.comAlpha Cognition (OTC:ACOGF) Stock Price Up 6.1%September 4, 2024 | marketbeat.comACOG:CA Alpha Cognition Inc.August 17, 2024 | seekingalpha.comAco Group Bhd (ACOG)August 15, 2024 | investing.comAlpha Cognition, Inc. On Track to Secure Financing for Continued GrowthAugust 13, 2024 | finance.yahoo.comAlpha Cognition Announces Financial Results for the Second Quarter and Six Months Ended June 2024 and Provides Corporate UpdateAugust 12, 2024 | finance.yahoo.comCognition Therapeutics: Shines Less Bright After Phase 2 Results In Alzheimer's DiseaseAugust 1, 2024 | seekingalpha.comAlpha Cognition's Oral Therapy ZUNVEYL® Receives FDA Approval to Treat Alzheimer's DiseaseJuly 31, 2024 | stockhouse.comAlpha Cognition Inc Ordinary Shares ACOGJuly 29, 2024 | morningstar.comMFDA approves Alpha Cognition's Zunveyl to treat Alzheimer's DiseaseJuly 29, 2024 | msn.comAlpha Cognition’s Oral Therapy ZUNVEYL® Receives FDA Approval to Treat Alzheimer's DiseaseJuly 29, 2024 | finance.yahoo.comAlpha Cognition stock jumps on Alzheimer's drug approvalJuly 29, 2024 | msn.com Get Alpha Cognition News Delivered to You Automatically Sign up to receive the latest news and ratings for ACOGF and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ACOGF Media Mentions By Week ACOGF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ACOGF News Sentiment▼0.000.92▲Average Medical News Sentiment ACOGF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ACOGF Articles This Week▼00▲ACOGF Articles Average Week Get the Latest News and Ratings for ACOGF and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Alpha Cognition and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Protalix BioTherapeutics News Inhibikase Therapeutics News Invizyne Technologies News CEL-SCI News ZIVO Bioscience News Cortexyme News AlloVir News AIM ImmunoTech News NKGen Biotech News Calidi Biotherapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTC:ACOGF) was last updated on 9/17/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alpha Cognition Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alpha Cognition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ACOGF Stock Alerts